Corporate Board Profile
Tech Score: 14/100
1 mention(s) identify NEAL WALKER, D.O. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Aldeyra Therapeutics, Inc. | 2021-04-14 | Dr. Walker has co-founded and led a number of life science companies including: Octagon Research Solutions, Inc., a software and services provider to biopharmaceutical companies (acquired by Accenture plc). | Dr. Walker co-founded Octagon Research Solutions, Inc., a software and services provider to biopharmaceutical companies, indicating involvement in software development. He also has a strong background in biopharmaceutical and life science industries and an MBA. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-27 | Dr. Walker is the President and Chief Executive Officer at Aclaris Therapeutics, Inc., a privately held dermatological drug development company. He is a board certified dermatologist and serial entrepreneur with over 18 years of experience in the biopharmaceutical industry. Prior to founding Aclaris Therapeutics, Inc. in 2012, he was co-founder, President and CEO of Vicept Therapeutics, Inc. (acquired by Allergan, Inc.) from 2009 to 2012. Dr. Walker has co-founded and led a number of life science companies: Octagon Research Solutions, Inc., a software and services provider to biopharmaceutical companies (acquired by Accenture plc); Trigenesis Therapeutics, Inc., a specialty dermatology company where he served as Chief Medical Officer (acquired by Dr. Reddys Laboratories Ltd); Cutix Inc., a commercial dermatology company that markets PreSun®, a sunscreen brand acquired from Bristol-Myers Squibb Co. He began his pharmaceutical industry career at Johnson and Johnson, Inc. Dr. Walker currently is on the Board of Directors of Sebacia, Inc and Follica, Inc (Executive Chairman). Dr. Walker previously served on the Board of Directors for Octagon, a contract research organization. He is also on the Advisory Board of Flexible Medical Systems LLC, a privately held medical device company. Dr. Walker received his MBA from The Wharton School, University of Pennsylvania, his D.O. from Philadelphia College of Osteopathic Medicine and a B.A. in Biology from Lehigh University. |
| 2016-04-25 | Dr. Walker received his MBA from The Wharton School, University of Pennsylvania, his D.O. from Philadelphia College of Osteopathic Medicine and a B.A. in Biology from Lehigh University. Dr. Walker’s experience as a founder of two private pharmaceutical firms, strong background in clinical and product development in dermatology and other fields, and substantial knowledge of the pharmaceutical industry contributed to our conclusion that he should serve as a director of our company. |
| 2017-04-24 | Dr. Walker received his MBA from The Wharton School, University of Pennsylvania, his D.O. from Philadelphia College of Osteopathic Medicine and a B.A. in Biology from Lehigh University. |
| 2018-04-25 | Dr. Walker is the President and Chief Executive Officer and a director at Aclaris Therapeutics, Inc., a publicly-traded dermatological drug development company. Prior to founding Aclaris Therapeutics, Inc. in 2012, he was co-founder, President and CEO of Vicept Therapeutics, Inc. (acquired by Allergan, Inc.) from 2009 to 2012. |
| 2019-04-22 | Dr. Walker received his MBA from The Wharton School, University of Pennsylvania, his D.O. from Philadelphia College of Osteopathic Medicine and a B.A. in Biology from Lehigh University. |
| 2020-04-27 | Dr. Walker received his MBA from The Wharton School, University of Pennsylvania, his D.O. from Philadelphia College of Osteopathic Medicine and a B.A. in Biology from Lehigh University. |
| 2021-04-14 | Dr. Walker has co-founded and led a number of life science companies including: Octagon Research Solutions, Inc., a software and services provider to biopharmaceutical companies (acquired by Accenture plc). |
Data sourced from SEC filings. Last updated: 2026-03-05